1. Home
  2. SFNC vs LQDA Comparison

SFNC vs LQDA Comparison

Compare SFNC & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Simmons First National Corporation

SFNC

Simmons First National Corporation

HOLD

Current Price

$18.53

Market Cap

3.1B

Sector

Finance

ML Signal

HOLD

LQDA

Liquidia Corporation

HOLD

Current Price

$36.65

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SFNC
LQDA
Founded
1903
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
3.1B
IPO Year
1998
2020

Fundamental Metrics

Financial Performance
Metric
SFNC
LQDA
Price
$18.53
$36.65
Analyst Decision
Buy
Strong Buy
Analyst Count
6
11
Target Price
$22.83
$40.36
AVG Volume (30 Days)
936.9K
1.8M
Earning Date
04-21-2026
06-15-2026
Dividend Yield
4.55%
N/A
EPS Growth
N/A
51.81
EPS
N/A
N/A
Revenue
N/A
$158,320,000.00
Revenue This Year
$2,597.21
$208.46
Revenue Next Year
$4.06
$27.44
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1031.18
52 Week Low
$17.00
$11.26
52 Week High
$22.18
$46.67

Technical Indicators

Market Signals
Indicator
SFNC
LQDA
Relative Strength Index (RSI) 31.49 51.94
Support Level $18.48 $30.48
Resistance Level $18.66 $39.19
Average True Range (ATR) 0.60 2.15
MACD -0.17 0.44
Stochastic Oscillator 5.77 72.92

Price Performance

Historical Comparison
SFNC
LQDA

About SFNC Simmons First National Corporation

Simmons First National Corp is a financial holding company. The company through its subsidiaries is engaged in providing banking services including consumer, real estate and commercial loans, checking, savings and time deposits. The company's loan portfolio comprises construction, single-family residential and commercial loans; non-real estate loans, nonaccrual and past due loans; and credit card loans, student loans and other consumer loans. It also offers various products and services such as trust services, investments, agricultural finance lending, equipment lending, insurance, consumer finance and small business administration lending. The business activity of the firm is functioned through the region of the United States.

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.

Share on Social Networks: